These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 8133027)

  • 61. Beta 2-microglobulin-deficient mice demonstrate class II MHC restricted anti-viral CD4+ but not CD8+ CTL against influenza-sensitized autologous splenocytes.
    Taylor SF; Bender BS
    Immunol Lett; 1995 May; 46(1-2):67-73. PubMed ID: 7590931
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The CD8+ T cell repertoire in beta 2-microglobulin-deficient mice is biased towards reactivity against self-major histocompatibility class I.
    Glas R; Ohlén C; Höglund P; Kärre K
    J Exp Med; 1994 Feb; 179(2):661-72. PubMed ID: 8294874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. LCMV-specific, class II-restricted cytotoxic T cells in beta 2-microglobulin-deficient mice.
    Muller D; Koller BH; Whitton JL; LaPan KE; Brigman KK; Frelinger JA
    Science; 1992 Mar; 255(5051):1576-8. PubMed ID: 1347959
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Immunogenetic studies on the resistance of mice to highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, gamma-interferon induction and cytotoxic response.
    Schirrmacher V; Landolfo S; Zawatzky R; Kirchner H
    Invasion Metastasis; 1981; 1(3):175-94. PubMed ID: 6821364
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rejection of allogeneic and syngeneic but not MHC class I-deficient tumor grafts by MHC class I-deficient mice.
    Freland S; Chambers BJ; Andersson M; Van Kaer L; Ljunggren HG
    J Immunol; 1998 Jan; 160(2):572-9. PubMed ID: 9551890
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Perforin-dependent cytolytic responses in beta2-microglobulin-deficient mice.
    Smyth MJ; Snook MB
    Cell Immunol; 1999 Aug; 196(1):51-9. PubMed ID: 10486155
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Generation of CD8+ T cells specific for transporter associated with antigen processing deficient cells.
    Wolpert EZ; Petersson M; Chambers BJ; Sandberg JK; Kiessling R; Ljunggren HG; Kärre K
    Proc Natl Acad Sci U S A; 1997 Oct; 94(21):11496-501. PubMed ID: 9326638
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Identification of a tumor-associated contact-dependent activity which reversibly downregulates cytolytic function of CD8+ T cells.
    Levey DL; Udono H; Heike M; Srivastava PK
    Cancer Immun; 2001 Mar; 1():5. PubMed ID: 12747766
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Distinct phenotypes of antigen-selected CD8 T cells emerge at different stages of an in vivo immune response.
    Walker PR; Ohteki T; Lopez JA; MacDonald HR; Maryanski JL
    J Immunol; 1995 Oct; 155(7):3443-52. PubMed ID: 7561039
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Transfer of long-lasting tumor immunity by immune T cells from MHC congenic mice: migration, survival and tumor-protectivity of cytotoxic donor cells.
    Zangemeister-Wittke U; Schirrmacher V
    Biotherapy; 1991; 3(4):319-29. PubMed ID: 1786195
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Mechanism of induction of class I major histocompatibility antigen expression by murine leukemia virus.
    Faller DV; Wilson LD; Flyer DC
    J Cell Biochem; 1988 Mar; 36(3):297-309. PubMed ID: 3288646
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Germ-line transmission of a disrupted beta 2-microglobulin gene produced by homologous recombination in embryonic stem cells.
    Zijlstra M; Li E; Sajjadi F; Subramani S; Jaenisch R
    Nature; 1989 Nov; 342(6248):435-8. PubMed ID: 2685607
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Cross-priming of minor histocompatibility antigen-specific cytotoxic T cells upon immunization with the heat shock protein gp96.
    Arnold D; Faath S; Rammensee H; Schild H
    J Exp Med; 1995 Sep; 182(3):885-9. PubMed ID: 7650492
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Downregulation of T cell receptor expression by CD8(+) lymphocytes in kidney allografts.
    Mannon RB; Kotzin BL; Nataraj C; Ferri K; Roper E; Kurlander RJ; Coffman TM
    J Clin Invest; 1998 Jun; 101(11):2517-27. PubMed ID: 9616223
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Chemically induced sarcomas from nude mice are more immunogenic than similar sarcomas from congenic normal mice.
    Svane IM; Engel AM; Nielsen MB; Ljunggren HG; Rygaard J; Werdelin O
    Eur J Immunol; 1996 Aug; 26(8):1844-50. PubMed ID: 8765030
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Rejection of kidney allografts by MHC class I-deficient mice.
    Mannon RB; Nataraj C; Kotzin BL; Griffiths R; Geier S; Ibrahim S; Sanfilippo FP; Platt JL; Kurlander R; Coffman TM
    Transplantation; 1995 Mar; 59(5):746-55. PubMed ID: 7886804
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Beta 2-microglobulin/CD8 -/- mice reveal significant role for CD8+ T cells in graft rejection responses in beta 2-microglobulin -/- mice.
    Freland S; Ljunggren HG
    Scand J Immunol; 2000 Mar; 51(3):219-23. PubMed ID: 10736089
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Ontogeny of the alloimmune response against a transplanted tumor in Xenopus laevis.
    Robert J; Guiet C; Du Pasquier L
    Differentiation; 1995 Oct; 59(3):135-44. PubMed ID: 7589897
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Beta2-microglobulin-deficient NK cells show increased sensitivity to MHC class I-mediated inhibition, but self tolerance does not depend upon target cell expression of H-2Kb and Db heavy chains.
    Höglund P; Glas R; Ménard C; Kåse A; Johansson MH; Franksson L; Lemmonier F; Kärre K
    Eur J Immunol; 1998 Jan; 28(1):370-8. PubMed ID: 9485216
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The brain parenchyma is permissive for full antitumor CTL effector function, even in the absence of CD4 T cells.
    Walker PR; Calzascia T; Schnuriger V; Scamuffa N; Saas P; de Tribolet N; Dietrich PY
    J Immunol; 2000 Sep; 165(6):3128-35. PubMed ID: 10975826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.